Skip to main content
medRxiv
  • Home
  • About
  • Submit
  • ALERTS / RSS
Advanced Search

Characterising severe traumatic brain injury from fresh cerebral biopsy in living patients

View ORCID ProfilePing K. Yip, Shumaila Hasan, Christopher E.G. Uff
doi: https://doi.org/10.1101/2021.10.27.21265411
Ping K. Yip
1Queen Mary University of London, Barts and The London School of Medicine and Dentistry, Blizard Institute, Centre for Neuroscience, Surgery & Trauma, London E1 2AT, U.K.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Ping K. Yip
  • For correspondence: p.yip@qmul.ac.uk c.uff@qmul.ac.uk
Shumaila Hasan
2Department of Neurosurgery, Royal London Hospital, Whitechapel, London, E1 1FR, U.K.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Christopher E.G. Uff
1Queen Mary University of London, Barts and The London School of Medicine and Dentistry, Blizard Institute, Centre for Neuroscience, Surgery & Trauma, London E1 2AT, U.K.
2Department of Neurosurgery, Royal London Hospital, Whitechapel, London, E1 1FR, U.K.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • For correspondence: p.yip@qmul.ac.uk c.uff@qmul.ac.uk
  • Abstract
  • Full Text
  • Info/History
  • Metrics
  • Data/Code
  • Preview PDF
Loading

Abstract

Traumatic brain injury (TBI) is one of the most complex disorder in the most complex organ in the body and current classifications of mild, moderate and severe often fail to capture this complexity. Although the mainstay of prognosis involves several clinical classification systems, these systems are confined to macroscopic analysis. Therefore, we aim to use immunohistochemical examination of fresh brain biopsy samples to study the cellular and molecular changes caused by severe TBI.

Twenty-five adult patients suffering severe TBI were recruited into the Severe Head Injury Brain Analysis (SHIBA) study. Fresh brain biopsies obtained prior intracranial pressure (ICP) monitor insertion or during craniotomy underwent immunohistochemical analysis using the neuronal marker (NeuN), dendritic marker (MAP2), vascular markers (claudin-5 and vWF), and neuroinflammation markers (Iba1 and P2Y12) to investigate the injury severity at microscopic level.

Obtaining brain biopsy from the twenty-five patients in the study did not cause any additional burden to patient’s standard care and there were no adverse effects. The mean (± SD) Glasgow Outcome Scale-Extended (GOS-E) 3-months after injury was 4.0 (± 2.7), consisting of 64% unfavourable outcomes and 36% favourable outcomes. Immunostaining of brain tissue revealed various qualitative changes resulting in neuronal injury, dendritic injury, neurovascular injury, and neuroinflammation, which we classified into 4 subgroups for each injury type using the newly devised Yip, Hasan and Uff (YHU) grading system. Using this grading scale, patients with a total YHU grade of ≥ 11, 100% (n=11) had a GOS-E of ≤ 4, including death (54.5%), vegetative state (18.2%) and severe disability (27.3%) 3-months post injury. In contrast, those with a YHU grade of ≤ 8, 100% (n=8) had a GOS-E of 5 or higher, indicating a favourable outcome. Linear regression showed a significant negative correlation between the GOS-E and neuronal injury (R2 =0.240, p= 0.0129), dendritic injury (R2 =0.430, p= 0.0004), neurovascular injury (R2 =0.538, p<0.0001), and neuroinflammation (R2 =0.361, p= 0.0015).

Brain biopsy in severe TBI is a simple and safe procedure. Furthermore, immunofluorescence staining enables classification of this heterogeneous patient population into various categories of injury severity based on the cellular and molecular pathophysiology according to the YHU grading system. This new grading scale should facilitate a more precise diagnosis, similar to what is currently standard in oncology, allowing earlier and more accurate prognosis than current grading systems, thereby adding to the arsenal of resources available to guide clinical decision making in treating patients with severe TBI.

Competing Interest Statement

The authors have declared no competing interest.

Funding Statement

No funding was received towards this work.

Author Declarations

I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.

Yes

The details of the IRB/oversight body that provided approval or exemption for the research described are given below:

Ethical approval was granted by the London-Camden & Kings Cross Research Ethics Committee (REC ref: 20/LO/0074) and this application was supported by a patient and public involvement project where >90% of participants were supportive of brain biopsy in TBI(Hasan et al., 2019 Emerg. Med. Int.).

I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.

Yes

I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).

Yes

I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.

Yes

Data Availability

All data produced in the present study are available upon reasonable request to the authors.

  • Abbreviations

    EVD
    External ventricular drain
    GCS
    Glasgow coma scale
    GOS-E
    Glasgow Outcome Scale-Extended
    Iba1
    ionized calcium-binding adaptor molecule 1
    ICP
    Intracranial pressure
    IHC
    Immunohistochemistry
    IHP
    Independent Healthcare Professional
    INR
    International normalized ratio
    MAP2
    Microtubule-associated protein-2
    NeuN
    Neuronal nuclear protein
    OCT
    Optimal cutting temperature
    SHIBA
    Severe Head Injury Brain Analysis
    TBI
    Traumatic brain injury
    vWF
    von Willebrand factor
    YHU
    Yip, Hasan and Uff
  • Copyright 
    The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY-NC-ND 4.0 International license.
    Back to top
    PreviousNext
    Posted October 28, 2021.
    Download PDF
    Data/Code
    Email

    Thank you for your interest in spreading the word about medRxiv.

    NOTE: Your email address is requested solely to identify you as the sender of this article.

    Enter multiple addresses on separate lines or separate them with commas.
    Characterising severe traumatic brain injury from fresh cerebral biopsy in living patients
    (Your Name) has forwarded a page to you from medRxiv
    (Your Name) thought you would like to see this page from the medRxiv website.
    CAPTCHA
    This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
    Share
    Characterising severe traumatic brain injury from fresh cerebral biopsy in living patients
    Ping K. Yip, Shumaila Hasan, Christopher E.G. Uff
    medRxiv 2021.10.27.21265411; doi: https://doi.org/10.1101/2021.10.27.21265411
    Reddit logo Twitter logo Facebook logo LinkedIn logo Mendeley logo
    Citation Tools
    Characterising severe traumatic brain injury from fresh cerebral biopsy in living patients
    Ping K. Yip, Shumaila Hasan, Christopher E.G. Uff
    medRxiv 2021.10.27.21265411; doi: https://doi.org/10.1101/2021.10.27.21265411

    Citation Manager Formats

    • BibTeX
    • Bookends
    • EasyBib
    • EndNote (tagged)
    • EndNote 8 (xml)
    • Medlars
    • Mendeley
    • Papers
    • RefWorks Tagged
    • Ref Manager
    • RIS
    • Zotero
    • Tweet Widget
    • Facebook Like
    • Google Plus One

    Subject Area

    • Neurology
    Subject Areas
    All Articles
    • Addiction Medicine (230)
    • Allergy and Immunology (507)
    • Anesthesia (111)
    • Cardiovascular Medicine (1264)
    • Dentistry and Oral Medicine (207)
    • Dermatology (148)
    • Emergency Medicine (283)
    • Endocrinology (including Diabetes Mellitus and Metabolic Disease) (538)
    • Epidemiology (10056)
    • Forensic Medicine (5)
    • Gastroenterology (502)
    • Genetic and Genomic Medicine (2486)
    • Geriatric Medicine (240)
    • Health Economics (482)
    • Health Informatics (1653)
    • Health Policy (757)
    • Health Systems and Quality Improvement (638)
    • Hematology (250)
    • HIV/AIDS (538)
    • Infectious Diseases (except HIV/AIDS) (11896)
    • Intensive Care and Critical Care Medicine (627)
    • Medical Education (255)
    • Medical Ethics (75)
    • Nephrology (269)
    • Neurology (2304)
    • Nursing (140)
    • Nutrition (354)
    • Obstetrics and Gynecology (458)
    • Occupational and Environmental Health (537)
    • Oncology (1259)
    • Ophthalmology (377)
    • Orthopedics (134)
    • Otolaryngology (226)
    • Pain Medicine (158)
    • Palliative Medicine (50)
    • Pathology (326)
    • Pediatrics (737)
    • Pharmacology and Therapeutics (315)
    • Primary Care Research (282)
    • Psychiatry and Clinical Psychology (2295)
    • Public and Global Health (4850)
    • Radiology and Imaging (846)
    • Rehabilitation Medicine and Physical Therapy (493)
    • Respiratory Medicine (657)
    • Rheumatology (289)
    • Sexual and Reproductive Health (241)
    • Sports Medicine (228)
    • Surgery (273)
    • Toxicology (44)
    • Transplantation (131)
    • Urology (100)